Symyoo is a full-scope contract research organization (CRO) that specializes in managing phase I-IV clinical trials across various therapeutic areas. The company brings together a team of highly qualified professionals dedicated to customizing each project to meet client needs.
With a wide range of solutions, Symyoo collaborates with companies in the pharmaceutical, biotechnology, life science, and medical device industries. Their services include clinical development consulting, clinical directing, regulatory affairs, data management, biostatistics, and more. The company emphasizes the critical value of on-time delivery and commits to meeting time and budget expectations without compromising on quality.
Founded in 2009, Symyoo positions itself as a crucial partner in keeping clinical studies progressing smoothly and rapidly. To learn more, visit www.symyoo.co.kr.
There is no investment information
No recent news or press coverage available for Symyoo.